Clinically, there are distinct clinical and radiological features which distinguish MOGAD from multiple sclerosis and from aquaporin-4-seropositive neuromyelitis optica spectrum disorder (AQP4 + NMOSD) that have led to MOGAD being treated as a distinct disease [2, 3]. The gene discussed is AQP4; the disease is multiple sclerosis.